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Viral hepatitis is a major global health problem affecting millions of  people worldwide. The main objective of  the present study was 
to estimate the seroprevalence of  hepatitis C and hepatitis B in Saudi adults undertaking premarital screening voluntarily.
Methodology 
This observational retrospective study was conducted at King Khaled General Hospital, Al Majmaah, Saudi Arabia, for a period 
of  3 years (October 1, 2016 to September 30, 2019). The prevalence of  hepatitis B and hepatitis C infections was calculated using 
Microsoft Excel and the hematological data analysis was performed using SPSS software. A total of  3755 premarital Saudi adults who 
voluntarily participated in the premarital screening were included in this study. Subjects were screened for hepatitis C virus (HCV) and 
hepatitis B virus (HBV). The demographic and epidemiological parameters included patient age, sex, nationality, and seropositivity 
for HBV and/or HCV. 
Results
Of  the 3755 subjects, eight (0.242%) and 12 (0.364%) subjects were positive for HCV and HBV, respectively. Among the 12 HBV-
positive subjects, nine (75%) subjects were men, and three (25%) subjects were women. However, among the eight HCV-positive 
subjects, five (62.5%) subjects were men, and three (37.5%) subjects were women.
Conclusion 
This study concluded that the prevalence of  HBV infection was slightly higher than that of  HCV infection among the Saudi adult 
population of  Al Mjamaah. In addition, both HBV and HCV were less prevalent in women than in men in the study population.
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Introduction
Viral hepatitis being a major global health problem affects 
approximately 400 million people globally and is responsible 
for about 1.4 million deaths each year, most (95%) of  which 
are due to hepatitis B and hepatitis C1, 2. Viral hepatitis is 
caused by five different types of  viruses, including hepatitis 
virus A, B, C, D and E. The hepatitis B virus (HBV) and 
hepatitis C virus (HCV) can cause chronic hepatitis3, 4. HBV 
and HCV are transmitted through exposure to infected 
blood and/or semen. More than 95% of  the hepatitis 
B infected adults resolve the infection during the acute 
phase. However, about 80% of  the patients with hepatitis 
C progress to chronic infection1, 2, 4. Viral hepatitis is mostly 
diagnosed by testing the virus specific serological markers. 
The diagnosis of  HBV infection requires the detection 
of  few serological markers, including anti-HBs/anti-HBc 
antibodies, and HBsAg. HBsAg is the serological hallmark 
of  infection as it can be detected within 1–10 weeks post-
infection and its persistence for >6 months is indicative of  
chronic infection. HCV screening is generally performed 
using anti-HCV antibodies and is occasionally confirmed by 
HCV RNA test4
Hepatitis B is the most widespread viral hepatitis, with 
approximately 57 million people infected with HBV 
worldwide5. Its prevalence is higher in the Middle East 
than in Europe and the United States. Its prevalence ranges 
from 0.6% in Iraq to >8% in Sudan6. The number of  HBV-
infected persons in the Eastern Mediterranean region is 
>21 million (3.3% of  the population). Hepatitis C affects 
approximately 3% of  the world population; however, it 
has a high prevalence of  approximately 10% in developing 
countries3. In 2007, viral hepatitis was ranked as the second 
most common viral disease in Saudi Arabia7. Previously, in 
1998, Saudi Arabia witnessed a high prevalence (8.3%) of  
hepatitis B8. In a community based epidemiological study 
HBsAg seroprevalence of  approximately 7% was reported 
in Saudi children.  These reports of  high prevalence of  HBV 
led to state and scientific intervention, and as a result, the 
universal HBV immunization was started in the country in 
19899. The immunization program successfully resulted in a 
decrease in the prevalence of  HBV in the country10. Data on 
the prevalence of  HCV in Saudi Arabia are insufficient and 
controversial. The premarital screening program estimates 
the prevalence of  HCV to be 0.33%, while screening centers 
for blood donors indicate HCV infection rates of  0.4%–
1.1%11-15. In addition, HCV prevalence of  1.0 %–1.9% has 
been reported in a systematic review that included most of  
the published reports on the subject16. 
The insufficiency of  confirmed data leads to diminished 
planning for the prevention and treatment strategies of  the 
disease17. Hence, there is a need for considerable community-
based epidemiological studies to obtain more accurate 
incidence rate of  HCV and HBV infection in Saudi Arabia. 
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Therefore, the present study was performed to estimate 
the prevalence of  HBV and HCV infection among adult 
population of  Al Majmaah, Saudi Arabia. To accomplish this 
study, adults who attended the health service at King Khaled 
General Hospital (KKGH) for premarital screening were 
included and examined. The study population included adult 
men and women of  Saudi nationality from Al Majmaah. In 
addition, the effects of  HBV and HCV seropositivity on 
hematological parameters were also evaluated.
Materials and Methods 
Source/study population
The present study was conducted at the premarital screening 
center of  KKGH and involved 3755 adult Saudi people from 
the Al Majmaah region (1953 men and 1802 women, aged 
20–55 years). The 3-year clinical data (October 1, 2016 to 
September 30, 2019) 
were analyzed using 
a statistical analysis 
system. The study was 
approved by Central 
Institutional Review 
Board, Ministry of  




visiting the health 
service for premarital 
screening with no 
recent illness, surgery, 
or transfusion of  
blood or blood 
components were 
included in the study. 
Individuals who 
underwent premarital 
screening with a recent history of  health issues, major 
surgery, or transfusion of  blood and/or blood components 
in the previous 6 months were excluded from the study.
Blood sampling
Fresh whole blood (5 mL) was collected from all the study 
subjects and divided into two parts; one part was transferred 
to a tube containing ethylene diamine tetra acetic acid 
(EDTA), mixed gently and stored at ambient temperature 
and analyzed for hematological parameters within 48h of  
collection. The other part was transferred into a plain tube 
(without any anticoagulant) and allowed to clot by leaving it 
undisturbed at room temperature for 45–60 min. The clotted 
blood samples were centrifuged for 10 min at 1000g in a 
refrigerated centrifuge and the resulting supernatant (serum) 
from each sample was collected into separately labelled clean 
and sterile tubes and stored at –20°C until analysis. 
Serological tests for HCV and HBV
HCV and HBV serological markers were identified and 
evaluated using the ARCHITECT Immunoassay System 
(Abbott, Abbott Park, Illinois, USA) according to the 
manufacturer’s instructions. The detection of  HBV surface 
antigen (HBsAg) and anti-HCV antibodies was performed 
using HBsAg ULTRA kit (Bio-Rad, France) and anti-HCV 
PLUS version 3 kit (Bio-Rad, France), respectively. The 
initial screening results were confirmed by retesting positive 
samples18. 
Hematological analysis
Hematological tests for healthy normal individuals and HBV- 
and HCV-positive individuals were performed using an 
automated hematology analyzer, CELL-Dyn Ruby (Abbott 
Laboratories, Diagnostic Division, Abbott Park, Illinois, 
USA)
Statistical Analysis
Statistical analysis for estimating the prevalence of  HBV 
and HCV was performed using Microsoft Excel. The 
hematological data was analyzed by one-way ANOVA test 
using SPSS software. The results were considered statistically 
significant if  p values were <0.05.
Results
Seroprevalence of HBV and HCV
In total, 3755 participants (1953 [52.01%] men and 1802 
[47.99%] women) were recruited from October 1, 2016 to 
September 30, 2019. All participants were Saudi nationals 
aged 20–55 years. All participants underwent premarital 
screening and were examined for HBsAg and anti-HCV 
serum markers. As shown in Table 1, 0.32% (n = 12) and 
0.21% (n = 8) subjects were positive for HBsAg and anti-
HCV, respectively, and 99.47% (n = 3735) subjects were 
negative for both the serum markers tested. The yearly 
distribution of  HBV- and HCV-positive cases in the study 
population is shown in Figure 1. 
On further analysis of  our data and results, we observed that 
among the 1953 men, 99.28% (n = 1939) were seronegative, 
0.26% (n = 5) were positive for HCV, and 0.46% (n = 9) 
were positive for HBV (Table 2). Among the 1802 women, 
99.67% (n = 1796) were seronegative, 0.17% (n = 3) were 
positive for HCV, and 0.17% (n = 3) were positive for HBV 
(Table 2). Additionally, based on their age, we grouped the 
HBV and HCV seropositive men and women into two 
categories—>30 years old and <30 years old—and estimated 
the frequency of  HBV and HCV in both men and women 
according to age groups.
Fig. 1: Yearly distribution of the positive cases of HBV and HCV in 
the study population
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Among the nine HBV-positive men, two were <30 years 
old and seven were >30 years old. However, in three HBV-
positive women, one was >30 years old, and two were <30 
years old (Table 2). Similarly, among the five HCV-positive 
men, four were >30 years old and one was <30 years old, 
and among the three HCV-positive women, two were <30 
years old and one was >30 years old (Table 2). However, 
no cases of  HBV/HCV co-infection were identified in this 
study.
Hematological findings
As shown in Table 3, the analyzed hematological parameters, 
including hemoglobin levels, total RBC count, hematocrit, 
mean cell volume and mean cell hemoglobin concentration, 
did not show any statistically significant differences between 
HBV- or HCV-seropositive and seronegative individuals. 
However, a statistically significant difference was observed 
in the values of  mean cell hemoglobin (MCH) and red cell 
distribution width (RDW) of  the HBV-seropositive subjects 
compared to those of  the seronegative ones (p<0.005). 
Discussion
Premarital screening is particularly important because it 
can prevent diseases in the future generations and provide 
insight into the incidence of  several diseases in the adult 
population19. Premarital screening is mandatory in Saudi 
Arabia and provides an excellent platform to estimate 
the prevalence of  several diseases20. In Saudi Arabia, 
consanguineous marriages are the main factor for births with 
a high risk of  carrying a disease, especially viral hepatitis and 
hemoglobinopathies19. As there is a considerable incidence of  
hepatitis in Saudi Arabia, it is recommended to acquire data 
on the prevalence of  the disease for planning/improving its 
prevention and treatment strategies. However, the relevant 
studies reported in the literature are insufficient to acquire 
complete data. In this regard, we have previously reported 
the prevalence of  various transfusion-transmitted diseases, 
including HCV and HBV, in blood donors of  Al Majmaah, 
Saudi Arabia21. In the present study, we have reported 
the prevalence of  HCV and HBV in adult persons who 
underwent premarital screening at KKGH, Al Majmaah. 
The study results showed that seroprevalence of  HBV and 
HCV was higher in men (0.46% and 0.26%, respectively) than 
in women (0.17% and 0.17%, respectively). The prevalence 
of  HBV and HCV infection in couples tested through 
the premarital screening 
program in a previous similar 
study was 1.31% and 0.33%, 
respectively, which is slightly 
higher than that reported in 
our results15. Furthermore, 
a study conducted in the 
Qassim region showed that 
the positivity for HBV was 
0.7%, 1.5%, and 2.04% 
in 2008, 2009, and 2010, 
respectively. The same study 
also reported the prevalence 
of  HCV to be 0.1%, 3%, 
and 0.83% in 2008, 2009, 
and 2010, respectively22. 
The differences in the 
prevalence rates might be 
due to regional differences, as 
the studies were performed 
in different regions/cities of  Saudi Arabia. Furthermore, in 
these studies, the prevalence of  HBV infection was higher 
than that of  HCV infection, which is consistent with the 
results of  our study; however, the prevalence values reported 
in our study are lower than those reported in previous studies. 
Several studies have reported a decrease in the incidence 
and prevalence of  viral hepatitis B and C in Saudi Arabia 
over time18,23. Correspondingly, our results also revealed a 
lower prevalence of  HCV and HBV infection in the adult 
population. This decline in the prevalence of  HBV and 
HCV may be due to many factors, including timely active 
vaccination programs, mandatory premarital screening, and 
complementary immunological and therapeutic approaches 
that started in Saudi Arabia in 1989. 
In agreement with previous studies, our results confirmed 
that HBV infection was more prevalent than HCV infection 
in our study population. Further analysis of  seropositive 
results showed that the prevalence of  HBV and HCV 
infection was lower in women than in men, consistent 
Table 1:  Prevalence of viral hepatitis among 3755 participants 
undergoing premarital screening in Al Majmaah, Saudi Arabia 
(from October 1, 2016 to September 30, 2019)
Category No. of cases (n) Percentage (%)
HCV positive 8 0.21
HBV positive 12 0.32
HCV and HBV Negative 3735 99.47
Total 3755 100
Table 2: Combined results of HCV and HBV positive male 
and female cases/groups.
Total study population 
(N=3755)
HBV +ive cases 
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Table 3: Comparison of hematological parameters between healthy controls, HBV positive 
and HCV positive individuals
Hematologic parameters Healthy controls HBV positive  HCV positive  
RBC (106/mm3) 5.121 ± 0.24 4.95 ± 0.45 4.86 ± 0.45 
HB (g/dL)  14.912 ± 0.52 14.69 ± 0.88 14.36 ± 1.12 
HCT (%) 45.463 ± 4.09 45.98 ± 3.09 42.94 ± 2.8 
MCV (fL) 86.556 ± 3.66 89.55 ± 4.31 88.62 ± 4.7 
MCH (pg) 29.273 ± 0.75 30.47 ± 0.93 *** 29.56 ± 0.41 
MCHC (g/dL) 34.58 ± 0.86 35.26 ± 0.74 34.58 ± 0.43 
RDW 12.844 ± 0.86 12.13 ± 0.51 * 12.16 ± 0.56 
Values are shown as Mean ± SD. Hb: Hemoglobin, RBC: Red blood cell, HCT: hematocrit, MCH: mean cell 
hemoglobin, MCHC: mean cell hemoglobin concentration, MCV: mean cell volume, RBC: red blood cell, RDW: 
red cell distribution width. 
* Significant difference: * p<0.05 and *** p<0.001
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with previous studies conducted in the Riyadh region24,25. 
Hematological analysis revealed that the slight differences 
in the hematological parameter between the HBV- or HCV-
seropositive subjects and the seronegative individuals were 
statistically insignificant, except for MCH and RDW, that too 
in case of  HBV only (Table 3). Some of  our hematological 
findings are in agreement with those of  Ahmad et al (2018) 
and Sabry et al (2007)26,27, but not with some other findings 
available in literature28,29. Our main focus was to estimate the 
prevalence of  HBV and HBC, and the small sample size of  
HBV- and HCV-seropositive groups could be the reason for 
the some controversial results.
Conclusions
This study reports the prevalence of  HCV and HBV infection 
in the adult population of  Al Majmaah, emphasizing a higher 
prevalence of  HBV infection than that of  HCV infection 
and a higher prevalence of  both diseases in men than in 
women. 
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